Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
2.93
-0.07 (-2.33%)
At close: Sep 10, 2025, 3:59 PM
2.96
1.02%
Pre-market: Sep 11, 2025, 08:39 AM EDT
License Collaboration And Other Revenue Revenue
History
Quarter | Value | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 2.01M | 466K | +30.16% |
Mar 31, 2025 | 1.54M | -3.02M | -66.16% |
Dec 31, 2024 | 4.57M | 2.73M | +148.69% |
Sep 30, 2024 | 1.84M | -603K | -24.72% |
Jun 30, 2024 | 2.44M | 841K | +52.63% |
Mar 31, 2024 | 1.6M | -3.29M | -67.33% |
Dec 31, 2023 | 4.89M | 2.96M | +153.68% |
Sep 30, 2023 | 1.93M | -12.2M | -86.36% |
Jun 30, 2023 | 14.13M | 8.83M | +166.69% |
Mar 31, 2023 | 5.3M | -416K | -7.28% |
Dec 31, 2022 | 5.71M | -1.01M | -15.02% |
Sep 30, 2022 | 6.72M | -76.33M | -91.90% |
Jun 30, 2022 | 83.06M | 62.8M | +310.13% |
Mar 31, 2022 | 20.25M | -8.88M | -30.48% |
Dec 31, 2021 | 29.13M | 17.13M | +142.70% |
Sep 30, 2021 | 12M | -7.95M | -39.85% |
Jun 30, 2021 | 19.95M | -1.94M | -8.87% |
Mar 31, 2021 | 21.9M | -199K | -0.90% |
Dec 31, 2020 | 22.09M | -3.5M | -13.68% |
Sep 30, 2020 | 25.6M | -33.85M | -56.94% |
Jun 30, 2020 | 59.45M | 177K | +0.30% |
Mar 31, 2020 | 59.27M | 18.63M | +45.84% |
Dec 31, 2019 | 40.64M | 10.64M | +35.45% |
Sep 30, 2019 | 30M | 20M | +200.04% |
Jun 30, 2019 | 10M | -13.11M | -56.73% |
Mar 31, 2019 | 23.11M | -29.91M | -56.42% |
Dec 31, 2018 | 53.03M | n/a | n/a |